高级检索
当前位置: 首页 > 详情页

Severe eosinophilic asthma in Chinese C-BIOPRED asthma cohort.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. [2]Department of Respiratory Medicine, The Affiliated Hospital of Inner Mongolia Medical University, Huhhot, China. [3]Department of Respiratory Medicine, Xinqiao Hospital, Army Military Medical University, Chongqing, China. [4]Department of Respiratory Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China. [5]Department of Respiratory Medicine, Zhongshan Hospital, Shanghai, China. [6]Department of Respiratory Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. [7]Department of Respiratory Medicine, Shanghai Tongji Hospital, Shanghai, China. [8]Department of Respiratory Medicine, The First Affiliated Hospital of PLA General Hospital, Beijing, China. [9]Department of Respiratory, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. [10]AstraZeneca, Shanghai, China. [11]Department of Respiratory Medicine, The First Hospital of China Medical University, Shenyang, China. [12]Department of Respiratory Medicine, The First People's Hospital of Yunnan Province, Kunming, China. [13]Department of Respiratory Medicine, Jiangsu Province Hospital, Nanjing, China. [14]Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Shanghai, China. [15]Department of Respiratory Medicine, Beijing Chao-Yang Hospital, Beijing, China. [16]Department of Respiratory Medicine, Shanghai General Hospital, Shanghai, China. [17]Department of Respiratory Medicine, Guizhou Province People's Hospital, Guiyang, China. [18]Department of Respiratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. [19]Department of Respiratory Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, China. [20]Department of Respiratory Medicine, The Third Xiangya Hospital of Central South University, Changsha, China. [21]Department of Respiratory Medicine, Qingdao Municipal Hospital, Qingdao, China. [22]Department of Respiratory Medicine, Peking University Third Hospital, Beijing, China. [23]Department of Respiratory Medicine, Nanfang Hospital of Southern Medical University, Guangzhou, China. [24]Department of Respiratory Medicine, The General Hospital of Shenyang Military, Shenyang, China. [25]Department of Respiratory Medicine, Weifang Asthma hospital, Weifang, China. [26]Department of Respiratory Medicine, Peking University First Hospital, Beijing, China. [27]Department of Respiratory Medicine, The Second Xiangya Hospital of Central South University, Changsha, China. [28]College of Pulmonary and Critical Care Medicine, Chinese PLA General Hospital, Beijing, China. [29]Department of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China. [30]Department of Respiratory Medicine, The First Hospital of Changsha, Changsha, China. [31]Department of Respiratory Medicine, Navy General Hospital, Beijing, China. [32]National Heart and Lung Institute, Imperial College London, & Royal Brompton & Harefield NHS Foundation Trust, London, SW3, UK.
出处:
ISSN:

关键词: blood eosinophil count cigarette smoking exacerbations fractional exhaled nitric oxide severe asthma

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 2 区 医学
小类 | 2 区 医学:研究与实验 3 区 肿瘤学
最新[2023]版:
大类 | 1 区 医学
小类 | 2 区 医学:研究与实验 2 区 肿瘤学
JCR分区:
出版当年[2021]版:
Q1 MEDICINE, RESEARCH & EXPERIMENTAL Q1 ONCOLOGY
最新[2023]版:
Q1 ONCOLOGY Q1 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]Department of pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
通讯作者:
通讯机构: [1]Department of pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. [32]National Heart and Lung Institute, Imperial College London, & Royal Brompton & Harefield NHS Foundation Trust, London, SW3, UK. [*1]Department of pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China [*2]National Heart and Lung Institute, Imperial College London, & Royal Brompton & Harefield NHS Foundation Trust, London SW3, UK
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:83045 今日访问量:0 总访问量:682 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号